Volmink J, Siegfried NL, van derMerwe L, Brocklehurst P. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane系统评价数据库 2007年,第1期。目录号: CD003510. DOI: 10.1002/14651858.CD003510.pub2, 2007.
Bhoopat L, Khunamornpong S, Lerdsrimongkol P, Sirivatanapa P, Sethavanich S, Limtrakul A, Gomutbuthra V, Kajanavanich S, Thorner PS, Bhoopat T. Effectiveness of short-term and long-term zidovudine prophylaxis on detection of HIV-1 subtype E in human placenta and vertical transmission. Journal of Acquired Immune Deficiency Syndrome 2005;40(5):545-50.
The Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double- blind, placebo-controlled trial. Lancet 2002;359(9313):1178-86.
Dabis F, Elenga N, Meda N, Leroy V, Viho I, Manigart O, Dequae-Merchadou L, Msellati P, Sombie I. 18-Month mortality and perinatal exposure to zidovudine in West Africa. AIDS 2001;15(6):771-9.
Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, Severin ST, Roels TH, Kouassi MK, Lackritz EM, Coulibaly IM, Greenberg AE. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d拀Ivoire: a randomised trial. Lancet 1999;353(9155):781-5.
Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. New England Journal of Medicine 1994;331(18):1173-80.
Limpongsanurak S, Thaithumyanon P, Chaithongwongwatthana S, Thisyakorn U, Ruxrungtham K, Kongsin P, Tarounotai, U., Chantheptaewan, N., Triratwerapong, T., Ubolyam, S., Phanuphak, P., Virutamasen, P., Hanwanich, M., Hawanon, P. and Chulasugondha, P. Short course zidovudine maternal treatment in HIV-1 vertical transmission: randomized controlled multicenter trial. Journal of the Medical Association of Thailand 2001;84 Suppl 1:S338-45.
Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, Chotpitayasunondh, T., Chearskul, S., Roongpisuthipong, A., Chinayon, P., Karon, J., Mastro, T.D. and Simonds, R.J. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 1999;353(9155):773-80.
Thistle, P., Gottesman, M., Pilon, R., Glazier, R.H., Arbess, G., Phillips, E., Wald, R.L., Chitsike, I., Simor, A., Chipato, T. and Silverman, M. A randomized control trial of an Ultra-Short zidovudine regimen in the prevention of perinatal HIV transmission in rural Zimbabwe. Central African Journal of Medicine 2004;50(9-10):79-84.
Guay, L.A., Musoke, P., Fleming, T., Bagenda, D., Allen, M., Nakabiito, C., Sherman, J., Bakaki, P., Ducar, C., Deseyve, M., Emel, L., Mirochnick, M., Fowler, M.G., Mofenson, L., Miotti, P., Dransfield, K., Bray, D., Mmiro, F. and Jackson, J.B. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354(9181):795-802.
Jackson, J.B., Musoke, P., Fleming, T., Guay, L.A., Bagenda, D., Allen, M., Nakabiito, C., Sherman, J., Bakaki, P., Owor, M., Ducar, C., Deseyve, M., Mwatha, A., Emel, L., Duefield, C., Mirochnick, M., Fowler, M.G., Mofenson, L., Miotti, P., Gigliotti, M., Bray, D. and Mmiro, F. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet 2003;362(9387):859-68.
Lallemant, M., Jourdain, G., Le Coeur, S., Mary, J.Y., Ngo-Giang-Huong, N., Koetsawang, S., Kanshana, S., McIntosh, K. and Thaineua, V Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. New England Journal of Medicine 2004;351(3):217-28.
Taha, T.E., Kumwenda, N.I., Gibbons, A., Broadhead, R.L., Fiscus, S., Lema, V., Liomba, G., Nkhoma, C., Miotti, P.G. and Hoover, D.R Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Lancet 2003;362(9391):1171-7.
Gray, G.E., Urban, M., Chersich, M.F., Bolton, C., van Niekerk, R., Violari, A., Stevens, W. and McIntyre, J.A A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers. AIDS 2005;19(12):1289-97.
UNAIDS. 2006 Report on the Global AIDS Epidemic. 日内瓦: UNAIDS, 2006.
World Health Organization. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report, April 2007. Geneva: World Health Organization, 2007.
Newell ML, Thorne C. Antiretroviral therapy and mother-to-child transmission of HIV-1. Expert Review Anti Infectious Therapy 2004;2(5):717-32.
World Health Organization. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants in resource-limited settings: towards universal access. Recommendations for a public health approach. 日内瓦: World Health Organization, 2006.
Dabis, F., Bequet, L., Ekouevi, D.K., Viho, I., Rouet, F., Horo, A., Sakarovitch, C., Becquet, R., Fassinou, P., Dequae-Merchadou, L., Welffens-Ekra, C., Rouzioux, C. and Leroy, V Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS 2005;19(3):309-18.
Eshleman, S.H., Hoover, D.R., Chen, S., Hudelson, S.E., Guay, L.A., Mwatha, A., Fiscus, S.A., Mmiro, F., Musoke, P., Jackson, J.B., Kumwenda, N. and Taha, T. Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. Journal of Infectious Diseases 2005;192(1):30-6.
Martinson, N., Morris, L., Gray, G., Moodley, D., Lupondwana, P., Chezzi, C., Cohen, S., Pillay, C., Puren, A., Ntsala, M., Sullivan, J., Steyn, J. and McIntyre, J.A.. HIV Resistance and Transmission following Single-dose Nevirapine in a PMTCT Cohort. 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, February 8 - 11 2004. Abstract 38. 2004.
Palmer, S., Boltz, V., Martinson, N., Maldarelli, F., Gray, G., McIntyre, J., Mellors, J., Morris, L. and Coffin, J Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission. Proceedings of the National Acadademy of Science U S A 2006;103(18):7094-9.
Johnson, J.A., Li, J.F., Morris, L., Martinson, N., Gray, G., McIntyre, J. and Heneine, W. Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated. Journal of Infectious Diseases 2005;192(1):16-23.
Flys, T.S., Donnell, D., Mwatha, A., Nakabiito, C., Musoke, P., Mmiro, F., Jackson, J.B., Guay, L.A. and Eshleman, S.H. Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission. Journal of Infectious Diseases 2007;195(5):711-5.
McIntyre, J., Martinson, N., Boltz, V., Palmer, S., Coffin, J., Mellors, J., Hopley, M., Kimura, T., Robinson, P., Mayers, D.L. and Trial 1413 Investigator Team Addition of short course Combivir (CBV) to single dose Viramune (sdNVP) for prevention of mother-to-child transmission of HIV-1 can significantly decrease the subsequent development of maternal NNRTI-resistant virus. XV Intl AIDS Conference, 11-16 July 2004, Bangkok. LbOrB09. 2004.
Martinson, N.A., Ekouevi, D.K., Dabis, F., Morris, L., Lupodwana, P., Tonwe-Gold, B., Dhlamini, P., Becquet, R., Steyn, J.G., Leroy, V., Viho, I., Gray, G.E. and McIntyre, J.A. Transmission Rates in Consecutive Pregnancies Exposed to Single-Dose Nevirapine in Soweto, South Africa and Abidjan, Cote d'Ivoire. Journal of Acquired Immune Deficicency Syndrome 2007; 45(2) 206-209.
Jourdain, G., Ngo-Giang-Huong, N., Le Coeur, S., Bowonwatanuwong, C., Kantipong, P., Leechanachai, P., Ariyadej, S., Leenasirimakul, P., Hammer, S. and Lallemant, M. Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. New England Journal of Medicine 2004;351(3):229-40.
Lockman, S., Shapiro, R.L., Smeaton, L.M., Wester, C., Thior, I., Stevens, L., Chand, F., Makhema, J., Moffat, C., Asmelash, A., Ndase, P., Arimi, P., van Widenfelt, E., Mazhani, L., Novitsky, V., Lagakos, S. and Essex, M. Response to antiretroviral therapy after a single, peripartum dose of nevirapine. New England Journal of Medicine 2007;356(2):135-47.
Giuliano, M., Palmisano, L., Galluzzo, C.M., Amici, R., Germinario, E., Okong, P., Kituuka, P., Mmirro, F., Magoni, M. and Vella, S. Selection of resistance mutations in pregnant women receiving zidovudine and lamivudine to prevent HIV perinatal transmission. AIDS 2003;17(10):1570-2.
Coffie, P., Ekouevi, D., Chaix, M.L., Tonwe-Gold, B., Toure, S., Viho, I., Amani-Bosse, c., Leroy, V., Rouzioux, C. and Dabis, F.Short-course Zidovudine and Lamivudine or single-dose Nevirapine-containing PMTCT Compromises 12-Month Response to HAART in African Women, Abidjan, Côte d’Ivoire (2003-2006)..14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, February 25 - 28 2007. Abstract 93LB
Creek, T.L., Ntumy, R., Seipone, K., Smith, M., Mogodi, M., Smit, M., Legwaila, K., Molokwane, I., Tebele, G., Mazhani, L., Shaffer, N. and Kilmarx, P.H. Successful introduction of routine opt-out HIV testing in antenatal care in Botswana. Journal of Acquired Immune Deficiency Syndrome 2007;45(1):102-7.